Funds crunch hits biotech sector

The biotechnology sector in the country is reeling from a funds crunch, affecting its business growth despite the industry attaining an average growth in the range of 15-20 per cent in the past......

US outsourcing drug research to India

In her swank headquarters just blocks from some of Mumbai's worst slums, Swati Piramal is midway through an impassioned pitch about revolutionising the world of drug discovery. Sanskrit passages of......

Dr Reddy's in Rs 2,500 cr bid for Betapharm

Dr Reddy's Laboratories has offered Euro 450-million (about Rs 2,500 crore) for acquiring German generic drugs major Betapharm Arzneimittel GmbH.The deal, if it goes through, will be the biggest......

Dr Reddy's on prowl in France, Germany

Dr Reddy's Laboratories is planning a big-ticket acquisition in Europe to strengthen its generics portfolio in the world's second largest drug market. To this end, the company is exploring suitable......